Poor
Not Aligned
Patient Risk:
Low
Summary
The majority of claims about milk, antacids, food effects, and enteric-coated aspirin are not supported by the provided label sections (only 5.1 Risk of Bleeding excerpt and no actual Section 4 text were provided). Only parts of the ulcer-history warning are partially supported.
Category Scores
Accurate Statements
Avoiding aspirin is recommended in patients with a history of active peptic ulcer disease because it can cause gastric mucosal irritation and bleeding.
5.1 Risk of Bleeding excerpt: "Avoid using aspirin in patients with a history of active peptic ulcer disease, which can cause gastric mucosal irritation and bleeding."
Unsupported Statements
Milk does not meaningfully neutralise aspirin in the way an antacid like calcium carbonate can.
Not addressed in the provided label sections (no milk/antacid mechanism content provided).
Aspirin can still irritate the stomach lining.
Not explicitly stated in the provided label excerpt; only GI side effects and peptic ulcer guidance are provided.
Drinking milk does not reliably prevent aspirin-related stomach irritation.
No provided label content about milk use or prevention of GI irritation.
Aspirin absorption and stomach effects depend more on how fast it dissolves and how much the stomach is protected by food than on whether milk chemically neutralises it.
No provided label content on dissolution rate, food protection, absorption mechanisms, or milk.
Taking aspirin with food can reduce irritation for some people.
No provided label content about taking aspirin with food to reduce irritation.
Milk is not a substitute for products designed to protect the stomach such as enteric-coated aspirin.
No provided label content about milk substitution or stomach-protective/enteric-coated products.
Milk may reduce how harsh aspirin feels for some people.
No provided label content about milk affecting symptom perception.
“Feels better” is not the same as reliably preventing aspirin-related gastritis or stomach upset.
No provided label content about milk, gastritis prevention, or the relationship between symptom relief and prevention.
Antacids or gastro-protective approaches are more directly aimed at preventing aspirin-related stomach irritation than milk.
No provided label content comparing antacids/gastro-protective approaches vs milk.
Enteric-coated aspirin is designed to pass through the stomach more intact and dissolve later in the intestine.
No provided label content describing enteric-coated aspirin design.
Enteric-coated aspirin can reduce stomach irritation compared with regular aspirin.
No provided label content comparing enteric-coated vs regular aspirin for stomach irritation.
Enteric-coated formulations are generally more relevant than drinking milk for reducing stomach pain from aspirin.
No provided label content addressing milk vs enteric-coated formulations for GI symptom reduction.
Avoiding or getting medical advice is especially important if a person has conditions where aspirin is not recommended.
No provided label content about general "conditions where aspirin is not recommended" and no provided instruction to seek medical advice in that framing.
Contradictions
Important Omissions
The provided label excerpt includes counseling about GI side effects and remaining alert for ulceration/bleeding signs, but the AI claims do not include this label-specific counseling content (signs/symptoms of GI side effects and what steps to take).
Importance:
Moderate
The provided label excerpt includes alcohol counseling (chronic heavy alcohol use bleeding risk) but the AI claims do not mention it.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The problematic content is largely nonspecific or unsupported (milk/antacid/enteric-coated mechanistic and comparative assertions). However, the only directly label-supported safety element present is the ulcer/bleeding history avoidance guidance; missing or unsupported messaging could be misleading but is not shown (from provided label excerpts) to directly contradict safety warnings.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most statements are not supported by the provided prescribing information excerpts (milk/antacid/food/enteric-coated comparative prevention claims are absent from provided label sections).
Suggested Improvement
Remove or rephrase unsupported milk/antacid/enteric-coated mechanistic and comparative claims; instead, rely only on provided label-supported warnings (e.g., avoid in active peptic ulcer disease) and include the label-specific GI bleeding/ulcer counseling elements when discussing prevention and when to seek help.